Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. It develops, manufactures, sells, and supports medical solutions. The company was founded by John R ...
Accuray has been witnessing a stable estimate revision trend for fiscal 2025. Over the past 30 days, the Zacks Consensus Estimate for earnings has remained stable at earnings of 1 cent per share.
MADISON, Wis. - Accuray (NASDAQ:ARAY) Incorporated (NASDAQ: ARAY), a radiation therapy company with annual revenues of $444.2 million, announced the appointment of Leonel Peralta as its new Senior ...
In this article, we are going to take a look at where Accuray Incorporated (NASDAQ:ARAY) stands against other robotics stocks to buy now. The robotics industry, which has grown modestly over the ...
Accuray Incorporated (NASDAQ: ARAY) and Halifax Health announced a breakthrough in cancer treatment at the Charles L. and Miki N. Grant Cancer Center for Hope in Port Orange, FL. Zacks Russell ...
Every investor in Accuray Incorporated (NASDAQ:ARAY) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 61% to be precise ...
Accuray Incorporated ARAY is well-poised for growth in the coming quarters, courtesy of continued robust demand for its products. The optimism, led by robust international performance in the ...